Sera Prognostics Ownership
| SERA Stock | USD 3.02 0.12 4.14% |
Shares in Circulation | First Issued 2020-03-31 | Previous Quarter 49.1 M | Current Value 49.5 M | Avarage Shares Outstanding 30.9 M | Quarterly Volatility 8.3 M |
Sera Stock Ownership Analysis
About 59.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.56. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sera Prognostics recorded a loss per share of 0.72. The entity had not issued any dividends in recent years. Sera Prognostics, Inc., a womens health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah. Sera Prognostics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 113 people. To find out more about Sera Prognostics contact Evguenia MBA at 801 990 0520 or learn more at https://www.sera.com.Besides selling stocks to institutional investors, Sera Prognostics also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Sera Prognostics' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Sera Prognostics' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Sera Prognostics Quarterly Liabilities And Stockholders Equity |
|
Sera Prognostics Insider Trades History
About 11.0% of Sera Prognostics are currently held by insiders. Unlike Sera Prognostics' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Sera Prognostics' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Sera Prognostics' insider trades
Sera Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Sera Prognostics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sera Prognostics backward and forwards among themselves. Sera Prognostics' institutional investor refers to the entity that pools money to purchase Sera Prognostics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Blackrock Inc | 2025-06-30 | 145.3 K | Perkins Capital Management Inc | 2025-06-30 | 131 K | State Street Corp | 2025-06-30 | 121.6 K | Ci Private Wealth Llc | 2025-06-30 | 100 K | Wealth Enhancement Advisory Services, Llc | 2025-06-30 | 99.2 K | Northern Trust Corp | 2025-06-30 | 91.6 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 91.4 K | Squarepoint Ops Llc | 2025-06-30 | 85.4 K | Cliftonlarsonallen Wealth Advisors, Llc | 2025-06-30 | 78.9 K | Baker Bros Advisors Lp | 2025-06-30 | 5.5 M | Whetstone Capital Advisors, Llc | 2025-06-30 | 3.6 M |
Sera Prognostics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sera Prognostics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sera Prognostics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Sera Prognostics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Sera Prognostics Outstanding Bonds
Sera Prognostics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Sera Prognostics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Sera bonds can be classified according to their maturity, which is the date when Sera Prognostics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Sera Prognostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sera Prognostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sera Prognostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sera Prognostics Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sera Prognostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Sera Stock refer to our How to Trade Sera Stock guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sera Prognostics. If investors know Sera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sera Prognostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.72) | Revenue Per Share | Quarterly Revenue Growth (0.45) | Return On Assets | Return On Equity |
The market value of Sera Prognostics is measured differently than its book value, which is the value of Sera that is recorded on the company's balance sheet. Investors also form their own opinion of Sera Prognostics' value that differs from its market value or its book value, called intrinsic value, which is Sera Prognostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sera Prognostics' market value can be influenced by many factors that don't directly affect Sera Prognostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sera Prognostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sera Prognostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sera Prognostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.